You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular Relapse

Showing 1 - 25 of 9,215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Bologna, Italy
    EMATOLOGIA- AOU Policlinico S.Orsola
Mar 1, 2022

Mantle Cell Lymphoma Trial in Warszawa, Wroclaw (Obinutuzumab)

Terminated
  • Mantle Cell Lymphoma
  • Warszawa, Poland
  • +1 more
Dec 23, 2021

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

Completed
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Angers, France
  • +9 more
Aug 17, 2022

ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant

Recruiting
  • ER+ Breast Cancer
  • HER2-negative Breast Cancer
  • Palbociclib 125Mg Tab
  • +5 more
  • Christchurch, United Kingdom
  • +3 more
May 19, 2022

Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

Not yet recruiting
  • Acute Myeloid Leukemia
  • Genetic Predisposition to Disease
  • Collection of blood sample of bone marrow (cohort 1)
  • Collection of blood sample of bone marrow (cohort 2 and 3)
  • (no location specified)
Mar 6, 2023

CBF and/or NPM1-mutated AML in First Molecular Relapse.

Recruiting
  • Acute Myeloid Leukemia
  • No intervention
  • Angers, France
    Angers University Hospital
Jun 14, 2021

AML Patients After Stem Cell Transplant to Understand Relapse

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Prospective determination of the clinical utility of measurable residual disease (MRD) testing
  • Duarte, California
  • +3 more
Dec 7, 2022

Glioblastoma Trial in Zhengzhou (Individualized intervention based on genomic alterations)

Enrolling by invitation
  • Glioblastoma
  • Individualized intervention based on genomic alterations
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Sep 10, 2022

MDS Trial in Bari, Rozzano (bone marrow withdrawal)

Recruiting
  • Myelodysplastic Syndromes
  • bone marrow withdrawal
  • Bari, Italy
  • +6 more
Oct 10, 2022

Prostate Cancer Trial (Early salvage radiotherapy (eSRT), Delayed Salvage radiotherapy (dSRT))

Not yet recruiting
  • Prostate Cancer
  • Early salvage radiotherapy (eSRT)
  • Delayed Salvage radiotherapy (dSRT)
  • (no location specified)
Aug 2, 2022

DLBCL, DLBCL Germinal Center B-Cell Type, DLBCL, Not Otherwise Specified Trial in Columbus (Molecular Nanotechnology)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Molecular Nanotechnology
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jun 2, 2022

Systemic Lupus Erythematosus (SLE) Trial in Marseille (polymerase chain reaction (PCR) technique of blood transcriptome

Terminated
  • Systemic Lupus Erythematosus (SLE)
  • polymerase chain reaction (PCR) technique of blood transcriptome analysis
  • Marseille, France
    Hôpital de la conception Assistance Publique Hôpitaux de Marseil
Aug 12, 2021

Circulating Tumor DNA in Surgical Patients With Lung Cancer

Active, not recruiting
  • Lung Cancer
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 12, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 16, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 22, 2023

    Indian Children With Acute Lymphoblastic Leukemia

    Not yet recruiting
    • ALL, Childhood
    • +7 more
      • New Delhi, India
      • +1 more
      Aug 22, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Dec 13, 2022

      hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

      Recruiting
      • Hepatocellular Carcinoma Recurrent
      • Liver Transplant; Complications
      • liver transplant
      • +2 more
      • Shanghai, China
        Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
      Jun 21, 2021

      Prostate Cancer Metastatic Trial in United States ([68Ga]-PSMA-R2)

      Completed
      Has Results
      • Prostate Cancer Metastatic
      • Phoenix, Arizona
      • +4 more
      Oct 26, 2020

      CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

      Recruiting
      • CML
      • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
      • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
        FUNDALEU
      Jun 29, 2023

      Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • Nivolumab, IV, 240 mg
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Jan 3, 2023

      AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

      Not yet recruiting
      • AML, Adult
      • Minimal Residual Disease
      • chidamide and azacitidine
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Sep 27, 2023

      ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)

      Recruiting
      • ALL, Recurrent, Adult
      • Frankfurt (Main), Hessen, Germany
      • +1 more
      Jan 6, 2022

      Non Small Cell Lung Cancer, EGFR Activating Mutation, EGFR DEL19 Trial in France (Plasma ctDNA, FFPE blocks)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • Plasma ctDNA
      • FFPE blocks
      • Angers, France
      • +35 more
      Sep 19, 2023

      Non-Invasive Artificial Intelligence-Based Platform MonIToring

      Recruiting
      • Breast Cancer
      • +2 more
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jul 21, 2022